• D-N-Acetylgalactosamine: Technical Guide for Glycoprotein Re

  2026-06-23

  D-N-Acetylgalactosamine enables precise analysis of glycoprotein composition and glycosylation pathways in neurological research, particularly for brain heteropolysaccharide investigations. It is best suited for workflows requiring high purity and aqueous or DMSO solubility, but should not be used in protocols needing ethanol solubility or long-term storage of solutions.

• D-N-Acetylgalactosamine: Technical Guidance for Brain Glycop

  2026-06-23

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite optimized for the analysis of glycoprotein structure and glycosylation pathways in brain tissue. Researchers should use this product in workflows demanding precise control over solubility and storage, and avoid protocols relying on ethanol solubility or extended solution storage.

• Ellagic Acid Enables Precision in CK2 Signaling & Cancer Ass

  2026-06-22

  Ellagic acid, a selective ATP-competitive CK2 inhibitor, empowers researchers to dissect cancer and senescence pathways with unprecedented specificity. This article details optimized workflows, troubleshooting insights, and translational use-cases for leveraging ellagic acid in advanced cancer biology and oxidative stress research.

• Efficacy of Fumagillin and Antiprotozoals Against Azumiobodo

  2026-06-22

  This study systematically evaluates 20 antiprotozoal agents, including Fumagillin, for their ability to inhibit Azumiobodo hoyamushi—the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings provide a comparative framework for antiparasitic drug selection in aquaculture and highlight Fumagillin as a moderate inhibitor with potential research applications.

• Panobinostat (LBH589): Applied Workflows in Epigenetic Resea

  2026-06-21

  Panobinostat (LBH589) empowers researchers to probe epigenetic regulation and apoptosis induction with unmatched potency and versatility, making it a critical tool for both cancer and fibrosis studies. This article translates recent advances—including in vivo myopia models and drug resistance assays—into actionable, troubleshooting-rich workflows for experimental success.

• Syringin Natural Product: Optimized Workflows in RCC Researc

  2026-06-20

  Syringin, a rigorously characterized natural product, enables targeted inhibition of RCC cell proliferation and enhances sunitinib efficacy through EGFR/PI3K/Akt pathway modulation. This article details experimental workflows, protocol parameters, and troubleshooting guidance for maximizing the impact of Syringin in bioactive compound research.

• Deferasirox Modulates Myeloid Differentiation via Mitochondr

  2026-06-19

  The reference study uncovers how Deferasirox, an oral iron chelator, differentially affects myeloid maturation by altering mitochondrial ROS levels and modulating NF-κB signaling. These findings offer mechanistic insights into iron chelation's hematopoietic effects, informing future research on iron overload treatment and the safe use of chelators in anemias.

• Eliminating Pollen Interference in Bioaerosol Hazard Detecti

  2026-06-19

  This study establishes a robust workflow for identifying and removing pollen spectral interference in the classification of hazardous bioaerosols using excitation emission matrix fluorescence spectroscopy (EEM) and machine learning. The approach significantly enhances the accuracy of detecting bacteria and toxins in complex airborne mixtures, providing a valuable advance for environmental biosurveillance and public health.

• CKI 7 dihydrochloride: Precision Casein Kinase 1 Inhibitor W

  2026-06-18

  CKI 7 dihydrochloride empowers researchers to dissect CK1-mediated pathways with unprecedented selectivity, delivering actionable insights into cancer signaling and circadian biology. This article bridges novel findings from NSCLC metastasis research to practical, optimized protocols and troubleshooting for high-impact experimental results.

• Bacitracin (B1670): Technical Guidance for Antibacterial Res

  2026-06-18

  Bacitracin (B1670) is a peptide antibiotic formulated for laboratory-based antibacterial research targeting bacterial cell wall and peptidoglycan synthesis in gram-positive and gram-negative bacteria. It is not suitable for diagnostic or medical applications. Researchers should adhere to technical protocols and workflow best practices to ensure reproducibility and data integrity.

• ISRIB (trans-isomer): Precision PERK Inhibitor for ER Stress

  2026-06-17

  ISRIB (trans-isomer) delivers targeted, high-potency PERK inhibition for dissecting ER stress signaling, apoptosis, and cognitive memory models. Its robust translational control and blood-brain barrier penetrance set new standards for experimental reliability in neurodegenerative disease research.

• Quercetin as a PI3K Inhibitor: Practical Workflows in Cancer

  2026-06-17

  Quercetin (SKU N1841) stands out as a dual-function PI3K inhibitor and anti-inflammatory agent, ideal for modeling apoptosis and neuroprotection in cancer and depression studies. This article delivers protocol-ready insights, troubleshooting strategies, and translational guidance supported by the latest neuroprotective findings.

• Regorafenib Suppresses Melanoma via RRM2 and ERK/E2F3 Pathwa

  2026-06-16

  A recent iScience study uncovers that Regorafenib (BAY 73-4506) inhibits melanoma progression by downregulating RRM2 and interfering with ERK/E2F3 signaling, resulting in suppressed proliferation and increased apoptosis of melanoma cells. These findings provide novel mechanistic insights and support expanded preclinical use of multikinase inhibitors in melanoma research.

• D-N-Acetylgalactosamine: Technical Guidance for Brain Glycop

  2026-06-16

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite optimized for the analysis of glycoprotein constituents in neurological research. It is not suitable for protocols requiring ethanol solubility or long-term storage of prepared solutions, making precise workflow planning and handling essential for consistent and reproducible results.

• Oleic Acid (C18:1(9Z)): Molecular Mechanisms and Translation

  2026-06-15

  Explore Oleic Acid (C18:1(9Z)) as a precision tool in lipid metabolism research. This article delivers a molecular deep dive and translational insights distinct from standard protocols and review content.

16433 records 1/1096 page Next 12345 下5页 Last page